Metin Kurtoglu - Chief Technology Officer at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Technology Officer
Stock Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Metin Kurtoglu - trading volume in the past year for Cartesian Therapeutics, Inc.

Holdings reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51K $948K $18.58 Nov 18, 2024 Direct
Stock Option (Right to Buy) 131K $104K $0.79 Nov 18, 2024 Direct Common Stock

Transactions reported by Metin Kurtoglu for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.